ClinicalTrials.gg
CompletedNCT05336045TH IIIUpdated Nov 27, 2024

Satisfaction and Recovery After Trigger Finger Release

An observational study in Trigger Finger Disorder, sponsored by Sahlgrenska University Hospital. Completed at 1 site in Sweden. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-27.

Sponsored by Sahlgrenska University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
18 Years and older
Sex
All
01

Study summary

Trigger finger release is one of the most common procedures in hand surgery. However, little is known about the patient perceived outcome directly after surgery and the timespan to recovery of normal hand function.This study focuses on patient reported outcome scores within the first six weeks after surgery.

Read the detailed description

Patients scheduled for release of trigger finger are assessed regarding the following outcome measures:

  1. VAS score for pain
  2. VAS score for finger movement
  3. VAS score for fréquence of triggering
  4. HAKIR questionnaire (validated instrument for hand function in the Swedish national hand registry)
  5. Quick-DASH questionnaire.

After surgery, the patients records the following outcomes:

Each day: 1,2,3 and records of pain medication details Each week: 4,5

for 6 weeks

02

Conditions studied

  • Trigger Finger Disorder
03

In context

Trigger Finger Disorder

95 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.

This study's enrollment of 110 is above the median of 68 across 14 observational studies indexed under Trigger Finger Disorder.

Browse Trigger Finger Disorder studies →

Lead sponsor

Sahlgrenska University Hospital is the lead sponsor of 263 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patient scheduled for trigger finger release

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Trigger phenomenon and/or
  2. Tenderness volarly to MCP joint of affected finger/thumb
  3. Patient scheduled for trigger finger release
  4. Signed informed consent

Exclusion criteria

Exclusion Criteria:

  1. Concomitant hand injuries/ conditions
  2. Multiple fingers/thumbs to be treated
  3. Unable to read/understand instructions in Swedish
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (actual)
Patient registry
No

Interventions

  • Proceduretrigger finger release

    The A1 pulley and tendon sheath is divided in local anaestethic through a small incision in the palm

06

What researchers measure

Primary outcomes

  1. Self-assessed hand function

    change in total score of hand-specific questionnaire (HAKIR) week by week. Best score 100, worst 0

    Time frame: every week for 6 weeks

Secondary outcomes

  1. Pain (assessed by patient)

    change in Visual Analouge Scale-score day by day (0= worst, 10=best)

    Time frame: 6 weeks

  2. Movement of finger (self-assessed by patient)

    change in Visual Analouge Scale-score day by day (0= worst, 10=best)

    Time frame: 6 weeks

  3. Frequency of trigger phenomenon (self-assessed by patient)

    change in Visual Analouge Scale-score day by day (0= worst, 10=best)

    Time frame: 6 weeks

07

Study locations

1 site
  • Alingsås lasarett
    Alingsås, Sweden
08

References and documents

Individual participant data

Plan to share: Undecided — open repositry

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2022 to primary completion in Nov 2024, 31 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 6, 2022
First posted
Apr 20, 2022
StartActual
Apr 26, 2022
Primary completionActual
Nov 26, 2024
CompletionActual
Nov 26, 2024
Last update
Nov 27, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05336045
Responsible party
Joakim Stromberg (senior consultant surgeon, MD, PhD, Sahlgrenska University Hospital) — Principal investigator
First posted
Apr 20, 2022
Start date
Apr 26, 2022
Primary completion
Nov 26, 2024
Completion
Nov 26, 2024
Last update
Nov 27, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion